Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.
Please read the tutorial at this link. https://ebooknice.com/page/post?id=faq
We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.
For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.
EbookNice Team
Status:
Available0.0
0 reviews
ISBN 10: 0323673619
ISBN 13: 9780323673617
Author: Deepak L Bhatt
Opie's Cardiovascular Drugs: A Companion to Braunwald's Heart Disease
1: Drugs for Ischemic Heart Disease
Introduction
β-Blockers
Summary
Nitrates and Newer (or Nontraditional) Antianginals
Calcium Channel Blockers
Summary
Summary
2: Antihypertensive Therapies
Introduction
Drug Class Overview and Guidelines
Diuretics
Calcium Channel Blockers
Angiotensin-Converting Enzyme Inhibitors
Angiotensin II Receptor Blockers
Mineralocorticoid Receptor Antagonists
β-Blockers
Central Sympatholytic Agents
α1-Adrenoreceptor Antagonists
Direct Vasodilators
3: Heart Failure
Introduction
Acute Decompensated Heart Failure
Pharmacotherapy
Vasodilators
Novel Vasodilators
Inotropes
β-Adrenergic Agonists
Phosphodiesterase Inhibitors
Calcium Sensitizers
Novel Inotropes
Vasopressors
Special Situations
Heart Failure Patients With Reduced Ejection Fraction
Pharmacotherapy
Angiotensin-Converting Enzyme Inhibitors
4: Drugs for Diabetes
Metabolic Syndrome and Prediabetes
Diabetes Prevention
Cardiovascular Disease Risk Assessment
Value of Improved Glycemic Control
Importance of Large Cardiovascular Disease Outcome Trials
Drugs That Lower Cardiovascular Disease Risk
Drugs That Do Not Lower Cardiovascular Disease Risk
Hypoglycemia
Guidelines
Future Directions
5: Drugs for Obesity
Drug Class Overview and Guidelines
Weight Loss Intervention
Pathophysiology and Mechanism of Action
Conclusion
6: Lipid-Modifying Drugs
Inflammation and Atherogenesis
Prevention and Risk Factors
Blood Lipid Profile
Lipids in Special Population Groups
Dietary and Other Nondrug Therapy for Dyslipidemia
Drug Therapy for Dyslipidemia
Summary
7: Drugs Targeting Inflammation
Basic Concepts of Inflammation Biology
Stimuli for the Inflammatory Response
Central Hubs of Inflammatory Signaling (see Fig. 7.2)
Mediators
Conclusions, Challenges, and Future Perspective
8: Antithrombotic Drugs
Introduction
Thrombosis
Emerging Construct and Future Targets for Antithrombotic Therapy
Cardiovascular Drug Therapy
Platelet-Directed Therapies
Platelet P2Y12 Receptor Antagonists
Periprocedural Management of Antiplatelet Therapy
Intravenous Platelet GPIIb/IIIa Receptor Antagonists
Summary of Recommendations in Patients With ACS
Anticoagulants
Parenteral Anticoagulant Drugs
9: Antiarrhythmic Drugs
Overview of New Developments
Antiarrhythmic Drugs
Inhaled Agents
New Developments in Antiarrhythmics
Antiarrhythmic Choice for Arrhythmias
Summary
10: Vascular Medicine Drugs
Overview
11: Drugs for Pulmonary Hypertension
Drug Class Overview and Guidelines
Mechanisms of Action
Differences Among Drugs in Class
Data for Use
Side Effects
Drug Interactions
Experimental Drugs
opie's cardiovascular drugs pdf
opie’s cardiovascular drugs
opie cardiovascular drugs
opie's cardiovascular drugs free download
opie cardiovascular drugs pdf download
Tags: Deepak L Bhatt, Cardiovascular, Drugs
5.0
15 reviews
5.0
14 reviews
4.6
29 reviews
4.4
36 reviews
4.6
13 reviews
5.0
28 reviews